Letter to the editor concerning 'Trastuzumab emtansine (T-DM1) versus lapatinib plus capecitabine in patients with HER2-positive metastatic breast cancer and central nervous system metastases: a retrospective, exploratory analysis in EMILIA'

Ann Oncol. 2015 May;26(5):1033-1034. doi: 10.1093/annonc/mdv040. Epub 2015 Jan 28.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antibodies, Monoclonal, Humanized / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Central Nervous System Neoplasms / secondary*
  • Deoxycytidine / analogs & derivatives*
  • Female
  • Fluorouracil / analogs & derivatives*
  • Humans
  • Maytansine / analogs & derivatives*
  • Quinazolines / therapeutic use*

Substances

  • Antibodies, Monoclonal, Humanized
  • Quinazolines
  • Deoxycytidine
  • Maytansine
  • Fluorouracil